Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
* Correspondence: Xiaoyong Zheng, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
We are located close to Rowlett, Sunnyvale, Garland, Texas
Not intended for: Use in humans or animals Diagnostic or therapeutic purposes Production of supplements or medicines Summary Epithalon (AEDG) is a synthetic tetrapeptide that is an analogue of a fragment of natural pineal epithalamine
Investigated for effects on cell motility, cytoskeletal organization, and tissue repair endpoints in tendon, ligament, and muscle in preclinical studies
Increased BMR & Mitochondrial Output: Enhances calorie burn and endurance potential (Kraus et al., Nature Medicine )